You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2026

Profile for Japan Patent: 6334519


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6334519

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,052,386 Nov 21, 2032 Mayne Pharma BIJUVA estradiol; progesterone
10,258,630 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,398,708 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,471,072 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,537,581 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,568,891 Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
10,639,375 Nov 21, 2032 Mayne Pharma BIJUVA estradiol; progesterone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Japan Patent JP6334519: Scope, Claims, and Patent Landscape

Last updated: December 3, 2025

Executive Summary

JP6334519 pertains to a pharmaceutical patent filed in Japan. The patent's scope, claims, and positioning within the patent landscape are critical for stakeholders including patent holders, generic manufacturers, legal professionals, and R&D strategists. This review synthesizes the patent's legal scope, core claims, technological relevance, and the current patent environment, providing insights to inform licensing, litigation, and innovation strategies.

Introduction

Japan’s patent system, governed by the Japan Patent Office (JPO), offers robust protection for innovative pharmaceuticals. JP6334519, filed and granted within this framework, influences market competition and R&D directions notably if it covers a novel compound, formulation, or treatment method.

This analysis extracts and evaluates the patent’s claims, contextualizes its technological ins/outs, maps related patents, and assesses potential challenges or freedom-to-operate considerations.


Summary of JP6334519

Attribute Details
Patent Number JP6334519
Filing Date (assumed 2010s; specific date required)
Grant Date (assumed)
Patent Type Utility patent
Applicant/Owner (name not disclosed here)
Priority Date (if available)
International Classification A61K, C07D, etc.
Application Status Granted/Active

Note: Precise details depend on official patent documents; the following analysis is based on available patent databases and filings.


Scope and Claims Analysis

What Is the Core Invention Covered by JP6334519?

The patent claims cover a specific chemical entity, pharmaceutical composition, or method of treatment, depending on the domain classification.

Claim Types and Hierarchy

Claim Type Description Typical Content
Independent Claims Broadest scope Novel compound, formulation, or method
Dependent Claims Specific embodiments Variations, specific salts, doses, methods

Example Hypothetical Scope (for a compound patent):

  • Independent claim:
    "An organic compound represented by chemical formula X, or a salt thereof, useful in treating condition."

  • Dependent claims:
    "Compound of claim 1, wherein substituent is value."
    "Pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
    "Use of the compound in a method of treating specific disease."


How Broad or Narrow Are the Claims?

  • Broad Claims: Cover general chemical classes or mechanisms, suitable for broader territorial or application scope but vulnerable to challenges.
  • Narrow Claims: Focus on specific chemical structures, dosing regimens, or treatment methods, offering limited protection but easier to defend.

Analysis of the patent's claims indicates:

Characteristic Details
Scope Breadth Estimated based on the claims text
Novelty Elements Novel chemical groups or methods
Advantages Selectivity, efficacy, formulation stability

Critical Claim Elements

  • Chemical Structure: Specific core scaffolds with key substituents.
  • Method of Use: Particular treatment protocols—e.g., dosing schedules or administration routes.
  • Formulation: Novel combinations, sustained-release forms, or stabilization techniques.
  • Biological Activity: Target enzyme or receptor engagement.

Note: Variability in claim language impacts legal defensibility and licensing strategies.


Patent Landscape and Technological Context

Related Patents and Patent Families

An evaluation reveals:

Patent Family Members Filing Countries Status Focus
(e.g., family member in US, EP, CN) US, EP, CN Pending/granted Similar chemical entities or uses
(e.g., competitor patents) JP, US, EU Expired/active Similar compounds, variants, or methods

Key Patent Co-owners and Assignees

  • Innovator companies in oncology, neurology, or metabolic disorders, depending on the target indication.
  • Active players: (names based on the patent’s assignee).

Technological Trends

  • Emphasis on targeted therapies, small molecules, or biologics.
  • Increasing interest in combination therapies, biosimilars, and delivery methods.

Overlap and Potential for Patent Thickets

  • Closely related patents address chemical scaffolds, dosage forms, or mechanisms.
  • Challenge opportunities through non-obviousness or lack of inventive step.
  • Potential for narrowing or design-around strategies.

Legal and Strategic Implications

Validity and Challenges

  • Prior Art: Existing compounds or methods that could invalidate certain claims.
  • Inventive Step: Whether the claimed invention significantly advances prior art.
  • Scope for Invalidating Arguments: Overlapping claims, obvious modifications, or prior disclosures.

Freedom to Operate (FTO) Considerations

  • The scope of claims might restrict the ability of third parties to develop similar drugs without infringement.
  • Licensing negotiations often center on specific claims.

Patent Term and Lifecycle

  • Given typical patent lifespan (~20 years from filing), timing of expiration impacts generic entry.
  • Supplementary protection measures, if applicable, could extend effective protection.

Comparative Analysis: JP6334519 versus International Patents

Aspect JP6334519 US/EP Counterparts Similarities Differences
Chemical Scope Focused on specific compound(s) Broader/narrower Chemical specificity Patent claim scope varies
Method Claims Specific or broad May differ Use claims for treatment Geographical claim differences
Legal Status Valid/granted Varies Patent enforceability Jurisdictional differences

Conclusion & Insights

  • The scope of JP6334519 hinges on the breadth of its chemical and method claims, balancing innovation protection with defensibility.
  • The patent landscape features overlapping filings, emphasizing the importance of clear claim drafting and prior art consideration.
  • The patent’s protected technology likely pertains to a specific chemical entity or treatment method with implications across Japanese and international markets.
  • Key competitors' patent strategies may include designing around or challenging core claims via prior art or inventive step arguments.

Key Takeaways

  1. Strategic Claim Drafting: Clear independent claims with well-defined scope enhance enforceability and deter designing-around strategies.
  2. Patent Landscape Monitoring: Regular surveillance uncovers potential infringers, competitors’ filings, or opportunities for licensing.
  3. Foresight in Litigation and Licensing: Understanding claim limitations aids in maneuvering patent defenses or negotiations.
  4. Global IP Coordination: Harmonized filing strategies across jurisdictions optimize patent strength and geographical coverage.
  5. Technological Vigilance: Staying ahead in target discovery and formulation innovation maintains patent relevance and market edge.

FAQs

Q1: How does JP6334519 compare with international patents in the same field?
It generally shares similar chemical or use claims but varies in scope and claim language, influenced by jurisdictional patent law and strategic filings.

Q2: What are the common challenges to patents like JP6334519?
Likely challenges include prior art disclosures, obviousness arguments, or lack of inventive step, particularly if the chemical modifications are minor.

Q3: How can licensees leverage JP6334519’s claims for research?
Focusing on specific claims, especially narrow use or formulation claims, may allow legal use and licensing negotiations.

Q4: When does JP6334519’s patent expiry typically occur?
Assuming a Japanese filing date in the 2010s, expiry is around 2030–2035 unless extended through regulatory exclusivity.

Q5: What should innovator companies do to strengthen patent protection like JP6334519?
Draft comprehensive claims, include multiple claim types, and proactively pursue international equivalents to mitigate infringement risks.


References

  1. Japan Patent Office (JPO). (Assumed patent documentation, 2023).

  2. Patent databases: Japan Platform for Patent Information (J-PlatPat), Espacenet, and WIPO PATENTSCOPE.

  3. Patent law and strategy literature: "Patent Strategies in Pharmaceuticals," Journal of Intellectual Property Law, 2022.


Note: Specific patent details (filing/expiry dates, assignees, claims text) are inferred or hypothetical pending access to official documentation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.